Sfoglia per RIVISTA
ANNALS OF ONCOLOGY : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Collezione AOU Città della Salute di Torino

  

Items : 30

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2025 Apr;36(4):361-374. doi: 10.1016/j.annonc.2025.01.022. Epub 2025 Feb 7.

2025
AOU Città della Salute di Torino

Musto P; Engelhardt M; van de Donk NWCJ; Gay F; Terpos E; Einsele H; Fernández de Larrea C; Sgherza N; Bolli N; Katodritou E; Gentile M; Royer B; Derudas D; Jelinek T; Zamagni E; Rosiñol L; Paiva B; Caers J; Kaiser M; Beksac M; Hájek R; Spencer A; Ludwig H; Cavo M; Bladé J; Moreau P; Mateos MV; San-Miguel JF; Dimopoulos MA; et alii...

2024
AOU Città della Salute di Torino

Di Maio M; Vetere G; Moretto R;

Reply to the Letter to the Editor "Importance of pain management in cancer patients and survivors" by K. Bhatt et al. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2024 May;35(5):475-476. doi: 10.1016/j.annonc.2024.01.007. Epub 2024 Feb 3.

2024
AOU Città della Salute di Torino

Di Maio M;

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2024 Jan;35(1):118-129. doi: 10.1016/j.annonc.2023.10.095. Epub 2023 Nov 3.

2024
AOU Alessandria
AOU Città della Salute di Torino

Anastasia A; Bottelli C; Ciccone G; Vitolo U; Boccomini C; Bossi E; Luminari S; Pennese E; Re F; Benedetti F; Latte G; Patti C; Pastore D; Ferreri AJM; Pinto A; Ghiggi C; Milone G; Cavallo F; Corradini P; Tani M; Gaidano G; Pavone V; Puccini B; Arcari A; Zilioli VR; Bolis S; Volpetti S; Tucci A; Botto B; et alii...

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Sep;33(9):988. doi: 10.1016/j.annonc.2022.05.004. Epub 2022 Jul 6.

2022
AOU Città della Salute di Torino

Boccadoro M; Einsele H; Facon T; Goldschmidt H; Cavo M; Schjesvold F; Cook G; Delforge M; Hájek R; Zweegman S; Mateos MV; Terpos E; Moreau P; Dimopoulos MA; San-Miguel J; Sonneveld P; Mey U;

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):20-33. doi: 10.1016/j.annonc.2021.09.005. Epub 2021 Sep 21.

2022
AOU Città della Salute di Torino

Schöffski P; Scheipl S; Sbaraglia M; Safwat AA; Sangalli C; Rutkowski P; Reichardt P; Piperno-Neumann S; Piana R; Pantaleo MA; Morosi C; Palmerini E; Montemurro M; Mir O; Miah AB; Messiou C; Merimsky O; Martin-Broto J; Lopez-Pousa A; Leithner A; Legius E; Le Grange F; Le Cesne A; Kopeckova K; Krákorová DA; Kawai A; Kasper B; Jutte P; Jungels C; et alii...

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5.

2022
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Scagliotti GV; Manegold C; Monica V; Porcu L; Wiest G; Irtelli L; Dickgreber NJ; Caffo O; Pedrazzoli P; Bearz A; Griesinger F; Follador A; Folprecht G; Schmid-Bindert G; Reck M; Chiari R; Gregorc V; Santo A; Morabito A; Schena M; Valmadre G; Borra G; Kropf-Sanchen C; Ceribelli A; Stoelben E; Cauchi C; Colantonio I; Geissler M; Meyer A; et alii...

Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):117. doi: 10.1016/j.annonc.2021.10.001. Epub 2021 Nov 29.

2022
AOU Città della Salute di Torino

Boccadoro M; Einsele H; Facon T; Goldschmidt H; Cavo M; Schjesvold F; Delforge M; Hájek R; Cook G; Zweegman S; Mateos MV; Terpos E; Moreau P; Dimopoulos MA; San-Miguel J; Sonneveld P; Mey U;

2022
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Porcu L; Manegold C; Scagliotti GV; Monica V; Wiest G; Irtelli L; Bearz A; Caffo O; Dickgreber NJ; Follador A; Pedrazzoli P; Griesinger F; Folprecht G; Reck M; Schmid-Bindert G; Santo A; Gregorc V; Chiari R; Morabito A; Borra G; Schena M; Kropf-Sanchen C; Valmadre G; Ceribelli A; Colantonio I; Cauchi C; Stoelben E; Ladage D; Geissler M; et alii...

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(?). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2021 Nov;32(11):1348-1365. doi: 10.1016/j.annonc.2021.07.006. Epub 2021 Jul 22.

2021
AOU Città della Salute di Torino

Schöffski P; Scheipl S; Sbaraglia M; Safwat AA; Sangalli C; Reichardt P; Rutkowski P; Piperno-Neumann S; Piana R; Pantaleo MA; Palmerini E; Morosi C; Morland B; Montemurro M; Mir O; Messiou C; Merimsky O; Martin-Broto J; Lopez-Pousa A; Leithner A; Legius E; Le Grange F; Le Cesne A; Kopeckova K; Krákorová DA; Kawai A; Kasper B; Kager L; Jutte P; et alii...

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(†). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2021 Mar;32(3):309-322. doi: 10.1016/j.annonc.2020.11.014. Epub 2021 Feb 3.

2021
AOU Città della Salute di Torino

Boccadoro M; Einsele H; Facon T; Goldschmidt H; Cavo M; Schjesvold F; Delforge M; Hájek R; Cook G; Zweegman S; Mateos MV; Terpos E; Moreau P; Dimopoulos MA; San-Miguel J; Sonneveld P; Mey U;

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Dec 1;30(12):2015. doi: 10.1093/annonc/mdz386.

2019
AOU Città della Salute di Torino

Ciavarella S; Vegliante MC; Fabbri M; De Summa S; Melle F; Motta G; De Iuliis V; Opinto G; Enjuanes A; Rega S; Gulino A; Agostinelli C; Scattone A; Tommasi S; Mangia A; Mele F; Simone G; Zito AF; Ingravallo G; Vitolo U; Chiappella A; Tarella C; Gianni AM; Rambaldi A; Zinzani PL; Casadei B; Derenzini E; Loseto G; Pileri A; et alii...

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Aug 1;30(8):1335-1343. doi: 10.1093/annonc/mdz138.

2019
AOU Città della Salute di Torino

Kreimer AR; Ferreiro-Iglesias A; Nygard M; Bender N; Schroeder L; Hildesheim A; Robbins HA; Pawlita M; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Smoller SW; Ness-Jensen E; Hveem K; D'Souza G; Visvanathan K; May B; Ursin G; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Brenner N; Hoffman-Bolton J; et alii...

Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Jul;29(7):1528-1534. doi: 10.1093/annonc/mdy140. Epub 2018 Apr 20.

2018
AO Cuneo
AOU Città della Salute di Torino

Falcone A; Fontanini G; Boni L; Sensi E; Zagonel V; Masi G; Allegrini G; Granetto C; Buonadonna A; Marmorino F; Tonini G; Zaniboni A; Loupakis F; Ronzoni M; Racca P; Moretto R; Cortesi E; Tomasello G; Lonardi S; Bergamo F; Antoniotti C; Cremolini C; Cremolini C; Antoniotti C; Lonardi S; Bergamo F; Cortesi E; Tomasello G; Moretto R; et alii...

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Dec 1;29(12):2363-2370. doi: 10.1093/annonc/mdy450.

2018
AOU Città della Salute di Torino

Ciavarella S; Vegliante MC; Fabbri M; De Summa S; Melle F; Motta G; De Iuliis V; Opinto G; Enjuanes A; Rega S; Gulino A; Agostinelli C; Scattone A; Tommasi S; Mangia A; Mele F; Simone G; Zito AF; Ingravallo G; Vitolo U; Chiappella A; Tarella C; Gianni AM; Rambaldi A; Zinzani PL; Casadei B; Derenzini E; Loseto G; Pileri A; et alii...

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Dec 1;29(12):2328-2333. doi: 10.1093/annonc/mdy414.

2018
AO Cuneo
AOU Città della Salute di Torino

Vicini R; Amaducci L; Bajardi EA; Beano A; Schirone A; Lombardo L; Moretti G; Giovanardi F; Pronzato P; Russo A; Cagossi K; Rimanti A; Zamagni C; Danese S; Maltoni R; Ferro A; Musolino A; Molino A; Gebbia V; Aieta M; Giotta F; Cavanna L; Piacentini F; Garrone O; Donadio M; Brandes AA; Bisagni G; Frassoldati A; Conte P; et alii...

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Apr 1;29(4):924-930. doi: 10.1093/annonc/mdy004.

2018
AOU Città della Salute di Torino

Dell'Aquila E; Cremolini C; Zeppola T; Lonardi S; Bergamo F; Masi G; Stellato M; Marmorino F; Schirripa M; Urbano F; Ronzoni M; Tomasello G; Zaniboni A; Racca P; Buonadonna A; Allegrini G; Fea E; Di Donato S; Chiara S; Tonini G; Tomcikova D; Boni L; Falcone A; Santini D;

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Sep 1;28(9):2169-2178. doi: 10.1093/annonc/mdx289.

2017
AOU Città della Salute di Torino

Dreyling M; Morschhauser F; Bouabdallah K; Bron D; Cunningham D; Assouline SE; Verhoef G; Linton K; Thieblemont C; Vitolo U; Hiemeyer F; Giurescu M; Garcia-Vargas J; Gorbatchevsky I; Liu L; Koechert K; Peña C; Neves M; Childs BH; Zinzani PL;

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Nov 1;28(11):2820-2826. doi: 10.1093/annonc/mdx439.

2017
AOU Città della Salute di Torino

Bossi P; Miceli R; Locati LD; Ferrari D; Vecchio S; Moretti G; Denaro N; Caponigro F; Airoldi M; Moro C; Vaccher E; Sponghini A; Caldara A; Rinaldi G; Ferrau F; Nolè F; Lo Vullo S; Tettamanzi F; Hollander L; Licitra L;

Second primary malignancies in multiple myeloma: an overview and IMWG consensus. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Feb 1;28(2):228-245. doi: 10.1093/annonc/mdw606.

2017
AOU Città della Salute di Torino

Musto P; Anderson KC; Attal M; Richardson PG; Badros A; Hou J; Comenzo R; Du J; Durie BGM; San Miguel J; Einsele H; Chen WM; Garderet L; Pietrantuono G; Hillengass J; Kyle RA; Moreau P; Lahuerta JJ; Landgren O; Ludwig H; Larocca A; Mahindra A; Cavo M; Mazumder A; McCarthy PL; Nouel A; Rajkumar SV; Reiman A; Riva E; et alii...

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Sep;27(suppl 5):v83-v90. doi: 10.1093/annonc/mdw400.

2016
AOU Città della Salute di Torino

Dreyling M; Ghielmini M; Rule S; Salles G; Vitolo U; Ladetto M;

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Sep;27(suppl 5):v91-v102. doi: 10.1093/annonc/mdw175. Epub 2016 Jul 4.

2016
AOU Città della Salute di Torino

Vitolo U; Seymour JF; Martelli M; Illerhaus G; Illidge T; Zucca E; Campo E; Ladetto M;

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 May;27(5):843-9. doi: 10.1093/annonc/mdw052. Epub 2016 Feb 9.

2016
AO Cuneo
AOU Città della Salute di Torino

Bustreo S; Ronzoni M; Buonadonna A; Bergamo F; Tomasello G; Tonini G; Allegrini G; Vitello S; Rossini D; Moretto R; Chiara S; Mancini ML; Granetto C; Lonardi S; Masi G; Loupakis F; Cremolini C; Barbara C; Boni L; Falcone A;

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Sep;26 Suppl 5:v116-25. doi: 10.1093/annonc/mdv304.

2015
AOU Città della Salute di Torino

Tilly H; Gomes da Silva M; Vitolo U; Jack A; Meignan M; Lopez-Guillermo A; Walewski J; André M; Johnson PW; Pfreundschuh M; Ladetto M;

Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Sep;26(9):1994-1999. doi: 10.1093/annonc/mdv272. Epub 2015 Jun 25.

2015
AOU Città della Salute di Torino

Barault L; Amatu A; Bleeker FE; Moutinho C; Falcomatà C; Fiano V; Cassingena A; Siravegna G; Milione M; Cassoni P; De Braud F; Rudà R; Soffietti R; Venesio T; Bardelli A; Wesseling P; de Witt Hamer P; Pietrantonio F; Siena S; Esteller M; Sartore-Bianchi A; Di Nicolantonio F;

Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factors. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Nov;26(11):2247-56. doi: 10.1093/annonc/mdv325. Epub 2015 Jul 27.

2015
AOU Città della Salute di Torino

Dimopoulos MA; Sonneveld P; Siegel D; Palumbo A; San-Miguel J;

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jun;26(6):1188-1194. doi: 10.1093/annonc/mdv112. Epub 2015 Feb 23.

2015
AO Cuneo
AOU Città della Salute di Torino

Di Donato S; Granetto C; Bonetti A; D'Amico M; Vitello S; Longarini R; Barone C; Tonini G; Spadi R; Zaniboni A; Tomasello G; Cortesi E; Salvatore L; Masi G; Lonardi S; Antoniotti C; Cremolini C; Loupakis F; Boni L; Falcone A;

Differences among young adults, adults and elderly chronic myeloid leukemia patients. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jan;26(1):185-192. doi: 10.1093/annonc/mdu490. Epub 2014 Oct 30.

2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rosti G; Pane F; Saglio G; Martinelli G; Cavo M; Alimena G; de Vivo A; Tiribelli M; Gozzini A; Russo D; Bonifacio M; Gobbi M; Cuneo A; Stagno F; Pregno P; Martino B; Abruzzese E; Rossi G; Iurlo A; Specchia G; Levato L; Baccarani M; Breccia M; Gugliotta G; Castagnetti F;

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Aug;26(8):1667-77. doi: 10.1093/annonc/mdv102. Epub 2015 Feb 23.

2015
AOU Città della Salute di Torino

Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS;

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Dec;25(12):2398-2404. doi: 10.1093/annonc/mdu462. Epub 2014 Oct 1.

2014
AOU Città della Salute di Torino

Mian M; Marcheselli L; Rossi A; Visco C; Chiappella A; Volpetti S; Zaja F; Mondello P; Fiegl M; Billio A; Federico M; Luminari S; Rambaldi A; Cortelazzo S;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte